Because our data showed that the platelet count is increased in DS-TB patients (Table 2), plasma levels of angiogenic-related factors such as PF4, PDGF-BB, VEGF-A, and MCP-1 were evaluated to assess if platelets were activated. The gene discussed is CCL2; the disease is Dravet syndrome.